These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30987386)

  • 21. GWASeq: targeted re-sequencing follow up to GWAS.
    Salomon MP; Li WL; Edlund CK; Morrison J; Fortini BK; Win AK; Conti DV; Thomas DC; Duggan D; Buchanan DD; Jenkins MA; Hopper JL; Gallinger S; Le Marchand L; Newcomb PA; Casey G; Marjoram P
    BMC Genomics; 2016 Mar; 17():176. PubMed ID: 26940994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies.
    Seaby EG; Ennis S
    Brief Funct Genomics; 2020 Jul; 19(4):243-258. PubMed ID: 32393978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Genetic Patterns of Complex Diseases via the Integrative Genome-Wide Approach.
    Teng B; Yang C; Liu J; Cai Z; Wan X
    IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(3):557-64. PubMed ID: 27295639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting X-linked common and rare variant effects in family-based sequencing studies.
    Turkmen AS; Lin S
    Genet Epidemiol; 2021 Feb; 45(1):36-45. PubMed ID: 32864779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability.
    Kierczak M; Rafati N; Höglund J; Gourlé H; Lo Faro V; Schmitz D; Ek WE; Gyllensten U; Enroth S; Ekman D; Nystedt B; Karlsson T; Johansson Å
    Nat Commun; 2022 May; 13(1):2532. PubMed ID: 35534486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.
    Keller MF; Saad M; Bras J; Bettella F; Nicolaou N; Simón-Sánchez J; Mittag F; Büchel F; Sharma M; Gibbs JR; Schulte C; Moskvina V; Durr A; Holmans P; Kilarski LL; Guerreiro R; Hernandez DG; Brice A; Ylikotila P; Stefánsson H; Majamaa K; Morris HR; Williams N; Gasser T; Heutink P; Wood NW; Hardy J; Martinez M; Singleton AB; Nalls MA; ;
    Hum Mol Genet; 2012 Nov; 21(22):4996-5009. PubMed ID: 22892372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation and the de novo assembly of human genomes.
    Chaisson MJ; Wilson RK; Eichler EE
    Nat Rev Genet; 2015 Nov; 16(11):627-40. PubMed ID: 26442640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic studies of complex phenotypes.
    Marian AJ
    Transl Res; 2012 Feb; 159(2):64-79. PubMed ID: 22243791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Analysis in the Age of Human Genome Sequencing.
    Lappalainen T; Scott AJ; Brandt M; Hall IM
    Cell; 2019 Mar; 177(1):70-84. PubMed ID: 30901550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenogenon: Gene to phenotype associations for rare genetic diseases.
    Pontikos N; Murphy C; Moghul I; Arno G; Fujinami K; Fujinami Y; Sumodhee D; Downes S; Webster A; Yu J;
    PLoS One; 2020; 15(4):e0230587. PubMed ID: 32271766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare-disease genetics in the era of next-generation sequencing: discovery to translation.
    Boycott KM; Vanstone MR; Bulman DE; MacKenzie AE
    Nat Rev Genet; 2013 Oct; 14(10):681-91. PubMed ID: 23999272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome sequencing and implications for rare disorders.
    Posey JE
    Orphanet J Rare Dis; 2019 Jun; 14(1):153. PubMed ID: 31234920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics challenges in genome-wide association studies (GWAS).
    De R; Bush WS; Moore JH
    Methods Mol Biol; 2014; 1168():63-81. PubMed ID: 24870131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome sequencing data analysis for rare disease gene discovery.
    Umlai UI; Bangarusamy DK; Estivill X; Jithesh PV
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34498682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical sequencing: From raw data to diagnosis with lifetime value.
    Caspar SM; Dubacher N; Kopps AM; Meienberg J; Henggeler C; Matyas G
    Clin Genet; 2018 Mar; 93(3):508-519. PubMed ID: 29206278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 'missing heritability' of common disorders: should health researchers care?
    Chaufan C; Joseph J
    Int J Health Serv; 2013; 43(2):281-303. PubMed ID: 23821906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into blood lipids from rare variant discovery.
    Schmidt EM; Willer CJ
    Curr Opin Genet Dev; 2015 Aug; 33():25-31. PubMed ID: 26241468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics.
    Hartin SN; Means JC; Alaimo JT; Younger ST
    Mol Med; 2020 Nov; 26(1):117. PubMed ID: 33238891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder.
    Thompson R; Papakonstantinou Ntalis A; Beltran S; Töpf A; de Paula Estephan E; Polavarapu K; 't Hoen PAC; Missier P; Lochmüller H
    Hum Mutat; 2019 Oct; 40(10):1797-1812. PubMed ID: 31231902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem repeat polymorphisms: modulators of disease susceptibility and candidates for 'missing heritability'.
    Hannan AJ
    Trends Genet; 2010 Feb; 26(2):59-65. PubMed ID: 20036436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.